Trial intelligence / Profile preview

Metoclopramide versus ondansetron versus placebo for nausea in emergency department adults

IRCT20180717040509N1Phase 3Completed

Sponsor
Mazandaran University of Medical Sciences
Start
Jan 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial comparing Ondansetron, Metoclopramide and Placebo normal saline (3 arms). Primary endpoint: Severity of nausea. Started Jan 2016; status: completed.

02

Drugs

ondansetronmetoclopramide

Beyond the preview

Go deeper on IRCT20180717040509N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180717040509N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call